生物医药投资部负责人、董事总经理 (Head of the Biopharmaceuticals Investment Department; Managing Director) at Shenzhen Capital Group · Joined 2012
View Live Interactive Profile →Zhou Yi leads Shenzhen Capital Group's Biopharmaceuticals Investment Department and holds the title of Managing Director. The group's team page states she holds a doctorate in medicinal chemistry, joined the group in 2012 and has research and investment experience, designates her a group gold medal investor, and lists her inclusion in Zero2IPO's 2018 F40 China young investors list and Securities Times' 2020 list of the top 10 investors in the healthcare industry. No companies are attributed to her individually by any first-party source found.